Beauty Health (NASDAQ:SKIN – Get Free Report) and PACS Group (NYSE:PACS – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and profitability.
Volatility and Risk
Beauty Health has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, PACS Group has a beta of -0.03, meaning that its share price is 103% less volatile than the S&P 500.
Insider & Institutional Ownership
93.3% of Beauty Health shares are held by institutional investors. 40.3% of Beauty Health shares are held by company insiders. Comparatively, 70.1% of PACS Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Beauty Health | $300.80 million | 0.28 | -$9.52 million | ($0.17) | -3.85 |
| PACS Group | $5.29 billion | 1.22 | $191.54 million | $1.23 | 33.37 |
PACS Group has higher revenue and earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent ratings for Beauty Health and PACS Group, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Beauty Health | 1 | 6 | 1 | 0 | 2.00 |
| PACS Group | 0 | 1 | 4 | 1 | 3.00 |
Beauty Health presently has a consensus price target of $2.32, suggesting a potential upside of 254.41%. PACS Group has a consensus price target of $44.40, suggesting a potential upside of 8.18%. Given Beauty Health’s higher probable upside, analysts plainly believe Beauty Health is more favorable than PACS Group.
Profitability
This table compares Beauty Health and PACS Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Beauty Health | -2.03% | -9.38% | -1.21% |
| PACS Group | 4.49% | 27.68% | 4.38% |
Summary
PACS Group beats Beauty Health on 12 of the 15 factors compared between the two stocks.
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
About PACS Group
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.
